These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 31774182)
21. Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome. Luo ZF; Qi W; Feng B; Mu J; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH Life Sci; 2011 Mar; 88(11-12):512-20. PubMed ID: 21241714 [TBL] [Abstract][Full Text] [Related]
22. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway. Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036 [TBL] [Abstract][Full Text] [Related]
23. [Effects of glibenclamide on mRNA level of ATP-sensitive potassium channels of heart in normal and streptozotocin-induced diabetic rats]. Li Y; Deng Q; Fu Z Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):538-40. PubMed ID: 11798815 [TBL] [Abstract][Full Text] [Related]
24. Protective effects of hydrogen sulfide in a rat model of traumatic brain injury via activation of mitochondrial adenosine triphosphate-sensitive potassium channels and reduction of oxidative stress. Jiang X; Huang Y; Lin W; Gao D; Fei Z J Surg Res; 2013 Oct; 184(2):e27-35. PubMed ID: 23590867 [TBL] [Abstract][Full Text] [Related]
25. Exogenous hydrogen sulfide prevents kidney damage following unilateral ureteral obstruction. Jiang D; Zhang Y; Yang M; Wang S; Jiang Z; Li Z Neurourol Urodyn; 2014 Jun; 33(5):538-43. PubMed ID: 23784934 [TBL] [Abstract][Full Text] [Related]
26. Hydrogen sulfide attenuates gastric mucosal injury induced by restraint water-immersion stress Sun HZ; Zheng S; Lu K; Hou FT; Bi JX; Liu XL; Wang SS World J Gastroenterol; 2017 Jan; 23(1):87-92. PubMed ID: 28104983 [TBL] [Abstract][Full Text] [Related]
28. P-Coumaric acid alleviates experimental diabetic nephropathy through modulation of Toll like receptor-4 in rats. Zabad OM; Samra YA; Eissa LA Life Sci; 2019 Dec; 238():116965. PubMed ID: 31629762 [TBL] [Abstract][Full Text] [Related]
29. Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats. Barzegar-Fallah A; Alimoradi H; Asadi F; Dehpour AR; Asgari M; Shafiei M Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):361-8. PubMed ID: 25676798 [TBL] [Abstract][Full Text] [Related]
30. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy. Wetzel MD; Gao T; Stanley K; Cooper TK; Morris SM; Awad AS Am J Physiol Renal Physiol; 2020 Feb; 318(2):F509-F517. PubMed ID: 31904280 [TBL] [Abstract][Full Text] [Related]
31. Modulation of heme oxygenase-1 expression and activity affects streptozotocin-induced diabetic nephropathy in rats. Ali MAM; Heeba GH; El-Sheikh AAK Fundam Clin Pharmacol; 2017 Oct; 31(5):546-557. PubMed ID: 28543864 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic insight into molsidomine, a nitric oxide donor in streptozotocin-induced diabetic nephropathy in rats. Minaz N; Razdan R Indian J Pharmacol; 2016; 48(5):544-549. PubMed ID: 27721541 [TBL] [Abstract][Full Text] [Related]
33. Zinc supplementation alleviates the progression of diabetic nephropathy by inhibiting the overexpression of oxidative-stress-mediated molecular markers in streptozotocin-induced experimental rats. Barman S; Pradeep SR; Srinivasan K J Nutr Biochem; 2018 Apr; 54():113-129. PubMed ID: 29331868 [TBL] [Abstract][Full Text] [Related]
34. Crocin mediated amelioration of oxidative burden and inflammatory cascade suppresses diabetic nephropathy progression in diabetic rats. Abou-Hany HO; Atef H; Said E; Elkashef HA; Salem HA Chem Biol Interact; 2018 Mar; 284():90-100. PubMed ID: 29409856 [TBL] [Abstract][Full Text] [Related]
35. Reduction of cellular stress is essential for Fibroblast growth factor 1 treatment for diabetic nephropathy. Wu Y; Li Y; Jiang T; Yuan Y; Li R; Xu Z; Zhong X; Jia G; Liu Y; Xie L; Xu K; Zhang H; Li X; Xiao J J Cell Mol Med; 2018 Dec; 22(12):6294-6303. PubMed ID: 30320493 [TBL] [Abstract][Full Text] [Related]
36. Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy. Gomes IB; Porto ML; Santos MC; Campagnaro BP; Pereira TM; Meyrelles SS; Vasquez EC Lipids Health Dis; 2014 Dec; 13():184. PubMed ID: 25481305 [TBL] [Abstract][Full Text] [Related]
37. Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats. Shukla R; Banerjee S; Tripathi YB BMC Complement Altern Med; 2018 May; 18(1):156. PubMed ID: 29751837 [TBL] [Abstract][Full Text] [Related]
38. Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model. El-Mahdy NA; El-Sayad ME; El-Kadem AH Biomed Pharmacother; 2016 Jul; 81():136-144. PubMed ID: 27261587 [TBL] [Abstract][Full Text] [Related]
39. Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats. Abdelrahman AM; Al Salam S; Al Suleimani Y; Ashique M; Manoj P; Ali BH Eur J Pharmacol; 2020 Apr; 873():172960. PubMed ID: 32001219 [TBL] [Abstract][Full Text] [Related]
40. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease. Sarookhani MR; Haghdoost-Yazdi H; Sarbazi-Golezari A; Babayan-Tazehkand A; Rastgoo N Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]